FDA perspectives on postmarket surveillance of peripheral and aortic vascular devices

Catheter Cardiovasc Interv. 2024 Jul;104(1):170-171. doi: 10.1002/ccd.31087. Epub 2024 May 19.

Authors

Misti Malone¹, Carmen Gacchina Johnson¹

Affiliation

¹ Office of Cardiovascular Devices, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland, USA.

PMID: 38764289
DOI: 10.1002/ccd.31087

No abstract available

Publication types

Editorial

MeSH terms

Blood Vessel Prosthesis
Device Approval
Endovascular Procedures / adverse effects
Endovascular Procedures / instrumentation
Endovascular Procedures / standards
Humans
Product Surveillance, Postmarketing* / standards
United States
United States Food and Drug Administration*
Vascular Access Devices / standards